STAT1 promotes megakaryopoiesis downstream of GATA-1 in mice

Journal of Clinical Investigation

Volumn 117, Issue 12, 2007, Pages 3890-3899

  Huang, Zan ^a   Richmond, Terri D ^b,c   Muntean, Andrew G ^a,e   Barber, Dwayne L ^b,c   Weiss, Mitchell J ^d   Crispino, John D ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 1; STAT1 PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN; TRANSCRIPTION FACTOR GATA 1;

ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; DOWN REGULATION; ERYTHROID CELL; FLOW CYTOMETRY; GENE EXPRESSION; INFLAMMATION; MEGAKARYOCYTE; MEGAKARYOPOIESIS; MOUSE; NONHUMAN; POLYPLOIDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PURIFICATION; SIGNAL TRANSDUCTION; STEM CELL; THROMBOCYTE COUNT; THROMBOCYTOPOIESIS; WESTERN BLOTTING;

ANIMALS; BLOOD PLATELETS; CELLS, CULTURED; GATA1 TRANSCRIPTION FACTOR; INFLAMMATION; INTERFERON REGULATORY FACTOR-1; INTERFERON TYPE II; MEGAKARYOCYTES; MICE; MICE, KNOCKOUT; PHOSPHORYLATION; PLATELET COUNT; PLOIDIES; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; STAT5 TRANSCRIPTION FACTOR; THROMBOCYTOSIS; THROMBOPOIESIS;

EID: 36849016548     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI33010     Document Type: Article

References (54)

1. Crispino, J.D. 2005. GATA1 in normal and malignant hematopoiesis. Semin. Cell Dev. Biol. 16:137-147.
2. Shivdasani, R.A., Fujiwara, Y., McDevitt, M.A., and Orkin, S.H. 1997. A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. EMBO J. 16:3965-3973.
3. Vyas, P., Ault, K., Jackson, C.W., Orkin, S.H., and Shivdasani, R.A. 1999. Consequences of GATA-1 deficiency in megakaryocytes and platelets. Blood. 93:2867-2875.
4. Muntean, A.G., and Crispino, J.D. 2005. Differential requirements for the activation domain and FOG-interaction surface of GATA-1 in megakaryocyte gene expression and development. Blood. 106:1223-1231.
5. Vannucchi, A.M., et al. 2002. Development of myelofibrosis in mice genetically impaired for GATA-1 expression (GATA-1(low) mice). Blood. 100:1123-1132.
6. Vannucchi, A.M., et al. 2005. Abnormalities of GATA-1 in megakaryocytes from patients with idiopathic myelofibrosis. Am. J. Pathol. 167:849-858.
7. Wechsler, J., et al. 2002. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat. Genet. 32:148-152.
8. Li, Z., et al. 2005. Developmental stage-selective effect of somatically mutated leukemogenic transcription factor GATA1. Nat. Genet. 37:613-619.
9. Kaushansky, K. 2005. The molecular mechanisms that control thrombopoiesis. J. Clin. Invest. 115:3339-3347.
10. Sattler, M., et al. 1995. The thrombopoietin receptor c-MPL activates JAK2 and TYK2 tyrosine kinases. Exp. Hematol. 23:1040-1048.
11. Drachman, J.G., Sabath, D.F., Fox, N.E., and Kaushansky, K. 1997. Thrombopoietin signal transduction in purified murine megakaryocytes. Blood. 89:483-492.
12. Kaushansky, K., and Drachman, J.G. 2002. The molecular and cellular biology of thrombopoietin: the primary regulator of platelet production. Oncogene. 21:3359-3367.
13. Kirito, K., and Kaushansky, K. 2006. Transcriptional regulation of megakaryopoiesis: thrombopoietin signaling and nuclear factors. Curr. Opin. Hematol. 13:151-156.
14. Neubauer, H., et al. 1998. Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell. 93:397-409.
15. Parganas, E., et al. 1998. Jak2 is essential for signaling through a variety of cytokine receptors. Cell. 93:385-395.
16. Benekli, M., Baer, M.R., Baumann, H., and Wetzler, M. 2003. Signal transducer and activator of transcription proteins in leukemias. Blood. 101:2940-2954.
17. Steensma, D.P., et al. 2006. JAK2 V617F is a rare finding in de novo acute myeloid leukemia, but STAT3 activation is common and remains unexplained. Leukemia. 20:971-978.
18. Snow, J.W., et al. 2002. STAT5 promotes multi-lineage hematolymphoid development in vivo through effects on early hematopoietic progenitor cells. Blood. 99:95-101.
19. Kirito, K., et al. 2002. A functional role of Stat3 in in vivo megakaryopoiesis. Blood. 99:3220-3227.
20. Ezoe, S., et al. 2005. GATA transcription factors inhibit cytokine-dependent growth and survival of a hematopoietic cell line through the inhibition of STAT3 activity. J. Biol. Chem. 280:13163-13170.
21. Kisseleva, T., Bhattacharya, S., Braunstein, J., and Schindler, C.W. 2002. Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene. 285:1-24.
22. Tsuji-Takayama, K., et al. 1996. IFN-gamma in combination with IL-3 accelerates platelet recovery in mice with 5-fluorouracil-induced marrow aplasia. J. Interferon Cytokine Res. 16:447-451.
23. Tsuji-Takayama, K., et al. 1996. Interferon-gamma enhances megakaryocyte colony-stimulating activity in murine bone marrow cells. J. Interferon Cytokine Res. 16:701-708.
24. Muraoka, K., et al. 1997. Thrombopoietin-independent effect of interferon-gamma on the proliferation of human megakaryocyte progenitors. Br. J. Haematol. 98:265-273.
25. Stachura, D.L., Chou, S.T., and Weiss, M.J. 2006. Early block to erythromegakaryocytic development conferred by loss of transcription factor GATA-1. Blood. 107:87-97.
26. Schroder, K., Hertzog, P.J., Ravasi, T., and Hume, D.A. 2004. Interferon-gamma: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 75:163-189.
27. Schulze, H., and Shivdasani, R.A. 2005. Mechanisms of thrombopoiesis. J. Thromb. Haemost. 3:1717-1724.
28. Ichikawa, M., et al. 2004. AML-1 is required for mega-karyocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis. Nat. Med. 10:299-304.
29. Elagib, K.E., et al. 2003. RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation. Blood. 101:4333-4341.
30. Muntean, A.G., et al. 2007. Cyclin D-Cdk4 is regulated by GATA-1 and required for megakaryocyte growth and polyploidization. Blood. 109:5199-5207.
31. Wang, Z., Zhang, Y., Kamen, D., Lees, E., and Ravid, K. 1995. Cyclin D3 is essential for megakaryocytopoiesis. Blood. 86:3783-3788.
32. Matsumura, I., et al. 2000. Increased D-type cyclin expression together with decreased cdc2 activity confers megakaryocytic differentiation of a human thrombopoietin-dependent hematopoietic cell line. J. Biol. Chem. 275:5553-5559.
33. Geng, Y., et al. 2003. Cyclin E ablation in the mouse. Cell. 114:431-443.
34. De Botton, S., et al. 2002. Platelet formation is the consequence of caspase activation within megakaryocytes. Blood. 100:1310-1317.
35. Ogilvy, S., et al. 1999. Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival. Proc. Natl. Acad. Sci. U. S. A. 96:14943-14948.
36. Kaluzhny, Y., et al. 2002. BclxL overexpression in megakaryocytes leads to impaired platelet fragmentation. Blood. 100:1670-1678.
37. Levine, R.L., Pardanani, A., Tefferi, A., and Gilliland, D.G. 2007. Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders. Nat. Rev. Cancer. 7:673-683.
38. Halupa, A., et al. 2005. A novel role for STAT1 in regulating murine erythropoiesis: deletion of STAT1 results in overall reduction of erythroid progenitors and alters their distribution. Blood. 105:552-561.
39. Wang, Q., Miyakawa, Y., Fox, N., and Kaushansky, K. 2000. Interferon-alpha directly represses megakaryopoiesis by inhibiting thrombopoietin-induced signaling through induction of SOCS-1. Blood. 96:2093-2099.
40. Kato, K., et al. 2003. Intracellular signal transduction of interferon on the suppression of haematopoietic progenitor cell growth. Br. J. Haematol. 123:528-535.
41. Ganser, A., Carlo-Stella, C., Greher, J., Volkers, B., and Hoelzer, D. 1987. Effect of recombinant interferons alpha and gamma on human bone marrow-derived megakaryocytic progenitor cells. Blood. 70:1173-1179.
42. Griffin, C.G., and Grant, B.W. 1990. Effects of recombinant interferons on human megakaryocyte growth. Exp. Hematol. 18:1013-1018.
43. Shiohara, M., Koike, K., and Nakahata, T. 1993. Synergism of interferon-gamma and stem cell factor on the development of murine hematopoietic progenitors in serum-free culture. Blood. 81:1435-1441.
44. Li, J., et al. 1998. Megakaryocytic differentiation of HIMeg-1 cells induced by interferon gamma and tumour necrosis factor alpha but not by thrombopoietin. Cytokine. 10:880-889.
45. Raslova, H., et al. 2007. Interrelation between polyploidization and megakaryocyte differentiation: a gene profiling approach. Blood. 109:3225-3234.
46. Jelinek, J., et al. 2005. JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia. Blood. 106:3370-3373.
47. Steensma, D.P. 2006. JAK2 V617F in myeloid disorders: molecular diagnostic techniques and their clinical utility: a paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology. J. Mol. Diagn. 8:397-411; quiz 526.
48. Walters, D.K., et al. 2006. Activating alleles of JAK3 in acute megakaryoblastic leukemia. Cancer Cell. 10:65-75.
49. Schafer, A.I. 2004. Thrombocytosis. N. Engl. J. Med. 350:1211-1219.
50. Griesshammer, M., et al. 1999. Aetiology and clinical significance of thrombocytosis: analysis of 732 patients with an elevated platelet count. J. Intern. Med. 245:295-300.
51. Hamada, T., et al. 1998. Transendothelial migration of megakaryocytes in response to stromal cell-derived factor 1 (SDF-1) enhances platelet formation. J. Exp. Med. 188:539-548.
52. Hodohara, K., Fujii, N., Yamamoto, N., and Kaushansky, K. 2000. Stromal cell-derived factor-1 (SDF-1) acts together with thrombopoietin to enhance the development of megakaryocytic progenitor cells (CFU-MK). Blood. 95:769-775.
53. Majka, M., et al. 2000. Stromal-derived factor 1 and thrombopoietin regulate distinct aspects of human megakaryopoiesis. Blood. 96:4142-4151.
54. Applied Biosystems. 1997. User Bulletin no. 2: ABI PRISM 7700 Sequence Detection System. docs. appliedbiosystems.com/pebiodocs/04303859.pdf.